Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P170022/S007

PyloPlus UBT System

Arj Medical, Inc. · Decision date Feb 5, 2026

FDA DECISIONP170022/S007

What did the FDA approve?

FDA records P170022/S007 as a supplement to PMA P170022, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Feb 5, 2026.

FDA approval order statement

Approval to add the PyloPlus UBT Auto Sampler used with glass breath collection tubes for use with the PyloPlus UBT System using the PyloPlus UBT Lab Analyzer (PPUBTLA -04), and for additions to test kit packaging.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Microbiology
Decision date
Feb 5, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P170022/S007
Regulatory pathway
PMA supplement
Product code
OZA
Decision code
APPR
Decision date
Feb 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Test, urea adult and pediatric (breath),.

Product code
OZA
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P170022/S007 received

    Application receipt date recorded by FDA.

  2. P170022/S008 · Related supplement

    PyloPlus Urea Breath Test System

  3. P170022/S007 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P170022. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170022

Product / regulatory recordCompanyPathwayDecision dateSource
Arj Medical, Inc.PMA supplementSep 16, 2025FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Arj Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
209 State St. E., Oldsmar, FL, 34677

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records
P170022/S007: PyloPlus UBT System | MedtechLedger